Call Us - We're Easy to Talk To (214) 999-9999

FDA Says Marketing Campaign for Dutasteride is Misleading

The AP (2/28, Perrone) reported, “A marketing campaign for a GlaxoSmithKline prostate drug has drawn complaints from federal regulators, who said the space-themed advertisement is misleading.” In an advertisement for Avodart [dutasteride] capsules, one actor recommends that another actor with frequent urination take the medication “adding that ‘other medicines, they don’t treat the cause, because they don’t shrink the prostate.'” But, Food and Drug Administration (FDA) “regulators say that claim is false. In a letter to the company’s US management, the FDA said Merck & Co. Inc.’s Proscar [finasteride] also reduces the size of the prostate, and has a similar indication.” The FDA also takes “issue with the visuals used to promote the drug. At one point the ad shows a man holding a model of a planet which is quickly replaced with a much smaller planet, to demonstrate Avodart’s prostate-shrinking power.” The agency “says the visual exaggerates the drug’s effect.”

From the American Association for Justice news release.

Bob Kraft

I am a Dallas, Texas lawyer who has had the privilege of helping thousands of clients since 1971 in the areas of Personal Injury law and Social Security Disability.

About This Blog

The title of this blog reflects my attitude toward those government agencies and insurance companies that routinely mistreat injured or disabled people. As a Dallas, Texas lawyer, I've spent more than 45 years trying to help those poor folk, and I have been frustrated daily by the actions of the people on the other side of their claims. (Sorry if I offended you...)

If you find this type of information interesting or helpful, please visit my law firm's main website at You will find many more articles and links. Thank you for your time.

Find us on your preferred network